Skip to main content
. 2023 Aug 24;382:e074258. doi: 10.1136/bmj-2022-074258

Table 2.

Results for 24 h urinary sodium excretion, potassium excretion, sodium-to-potassium ratio, and blood pressure

Outcomes Control Intervention Intervention v control
Baseline 12 months Change from baseline* (95% CI) Baseline 12 months Change from baseline* (95% CI) Difference in change* (95% CI) P value
No Mean (SD) No Mean (SD) No Mean (SD) No Mean (SD)
Salt, g/24 h 769 11.2 (5.0) 678 11.0 (4.7) −0.1 (−0.5 to 0.3) 761 11.1 (4.8) 667 10.1 (4.3) −1.0 (−1.3 to −0.6) −0.9 (−1.4 to −0.3) 0.002
Urinary sodium, mg/24 h 769 4418.7 (1973.7) 678 4330.9 (1859.8) −40.8 (−188.7 to 107.1) 761 4368.7 (1880.3) 667 3977.0 (1688.8) −377.6 (−526.3 to −228.9) −336.8 (−545.7 to −127.9) 0.002
Urinary potassium, mg/24 h 769 1578.5 (617.0) 678 1513.0 (598.6) −74.1 (−125.9 to −22.3) 761 1593.8 (616.3) 667 1542.4 (599.0) −59.6 (−11.6 to −7.5) 14.5 (−58.6 to 87.6) 0.70
Sodium-to-potassium ratio, mmol/mmol 769 5.07 (2.20) 678 5.26 (2.29) 0.27 (0.09 to 0.44) 761 4.98 (2.16) 667 4.73 (2.12) −0.21 (−0.39 to −0.03) −0.47 (−0.72 to −0.22) <0.001
Systolic blood pressure, mm Hg 790 128.9 (19.1) 713 130.5 (19.2) −0.03 (−1.20 to 1.15) 785 129.9 (19.14) 706 130.1 (18.16) −2.00 (−3.40 to −0.61) −1.98 (−3.54 to −0.41) 0.01
Diastolic blood pressure, mm Hg 790 80.1 (10.8) 713 80.1 (11.0) −0.34 (−1.06 to 0.37) 785 80.1 (11.27) 706 79.3 (11.28) −1.40 (−2.24 to −0.55) −1.05 (−2.01 to −0.10) 0.03

CI=confidence interval; SD=standard deviation.

*

Results were obtained from mixed linear model with random intercept of participants nested within family and random intercept of family nested within communities; all values for urinary outcomes were adjusted for age, sex, body mass index at baseline and follow-up, province, and education level. All values for blood pressure were further adjusted for outdoor temperature at baseline and follow-up, physical activity, and alcohol drinking status.

Comparison of means within each group. Positive values indicate increase from baseline to 12 month follow-up; negative values indicate decrease from baseline to 12 month follow-up.

Comparison between intervention group and control group in changes from baseline to 12 month follow-up. Positive values indicate that intervention group had greater increase or smaller decrease from baseline to 12 month follow-up compared with control group; negative values indicate that intervention group had greater decrease or smaller increase from baseline to 12 month follow-up compared with control group.